- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
EULAR European Congress of Rheumatology
Gout Flares Predicted by Monosodium Urate Deposits, Subclinical Inflammation
June 14, 2022
Differences among baseline clinical and laboratory characteristics between cases and controls were observed in those with a presence of subcutaneous tophi and higher serum urate levels.
Désirée van der Heijde, MD, PhD: Safety, Efficacy of Bimekizumab in Ankylosing Spondyloarthritis
June 14, 2022
Désirée van der Heijde, MD, PhD, explains the results of a recent trial evaluating the safety and efficacy of bimekizumab in patients with active ankylosing spondylitis.
Rheumatology Network's Top 5: June 11, 2022
June 11, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 11, 2022.
Frédéric Lavie, MD, PhD: Efficacy of Guselkumab Across Multiple Disease Domains of Psoriatic Arthritis
June 10, 2022
Frédéric Lavie, MD, PhD, explains the results of the data presented at EULAR evaluating guselkumab for the treatment of psoriatic arthritis.
Terence Rooney, MD: Innovative Aspects of Future-Facing Research in Psoriatic Arthritis
June 09, 2022
Terence Rooney, MD, explains the innovative research methods that Janssen utilizes and the benefits of precision medicine in the treatment of psoriatic arthritis.
Guselkumab Improves Health-Related Quality of Life in Patients with PsA
June 09, 2022
Terence Rooney, MD, discusses recent findings indicating that guselkumab provided patients with psoriatic arthritis with sustained improvements in health-related quality of life through 2 years.
Karin Schenck-Gustafsson, MD, PhD, FESC: Why Sex and Gender Must be Considered in Disease Treatment
June 08, 2022
Karin Schenck-Gustafsson, MD, PhD, FESC, explains why sex and gender must be taken into account when treating and managing patients with rheumatic disease from a cardiologist's perspective.
Line Uhrenholt, MD: Disease Activity-Guided Tapering in Patients with Inflammatory Arthritis
June 08, 2022
Line Uhrenholt, MD, discusses the results of her randomized, open-label, equivalence trial study evaluating disease activity-guided tapering of biologics in patients with inflammatory arthritis.
Patients with RA Hesitant to Make Changes to DMARD Therapy
June 07, 2022
Investigators believe that treatment escalation within patients with rheumatoid arthritis should utilize interventions beyond the traditional physician-patient relationship.
Patient-Provider Satisfaction Survey Affected by Cultural Norms in Hispanic/Latinx Patients with RA
June 04, 2022
A recent study, conducted by CreakyJoints, demonstrated that patient-reported satisfaction is affected by both social and cultural norms in Spanish-speaking patients with rheumatoid arthritis.